Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-001104

President and CEO acquired 10,063 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Luly Jay R. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-01-15 Exercise or conversion : show line 1 in the form +10,063 $11.77 $118,442 710,791 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-01-15 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −10,063 0 D
Loading xslF345X03/form4.xml…